Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose preoperative atorvastatin before cardiopulmonary bypass
2012-003396-20Phase 4Completed
- Sponsor
- Mater Misericordiae University Hospital
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin in Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by Mater Misericordiae University Hospital. Primary endpoint: Effect of high-dose preoperative statin on neutrophil migration. Started Sep 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on 2012-003396-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003396-20.